| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.76B | +10.4% |
| Cost of Revenue | $840.1M | +28.4% |
| Gross Profit | $1.92B | +8.9% |
| R&D Expense | $431.2M | +1.3% |
| SG&A Expense | $781.8M | -12.5% |
| Operating Income | -$1.05B | -387.7% |
| Interest Expense | $22.3M | +14.7% |
| Pre-tax Income | -$1.04B | -413.6% |
| Income Tax | -$7.3M | -404.0% |
| Net Income | -$1.03B | -404.0% |
| EPS (Basic) | -$5.59 | -394.7% |
| EPS (Diluted) | -$5.59 | -394.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $600.9M | -0.7% |
| Short-term Investments | $437.1M | +153.8% |
| Accounts Receivable | $249.0M | +22.3% |
| Inventory | $162.4M | +27.4% |
| Current Assets | $1.57B | +31.6% |
| Total Assets | $5.93B | -8.4% |
| Current Liabilities | $732.2M | +42.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $210.5M | +34.9% |
| Capital Expenditures | $136.0M | +9.5% |
| Investing Cash Flow | -$442.2M | -990.0% |
| Financing Cash Flow | $231.9M | +45.1% |
| Free Cash Flow | $74.5M | +133.5% |
| Long-term Debt |
| $50.0M |
| +0.0% |
| Total Liabilities | $3.53B | +6.0% |
| Stockholders' Equity | $2.40B | -23.6% |